The Latest Cardiac and Vascular News
BRONX, N.Y., March 28, 2022 /PRNewswire/ — Revving up a process that slows down as we age may protect against atherosclerosis, a major cause of heart attacks and strokes. In findings publishing online this week in Proceedings of the National Academy of Sciences (PNAS), scientists at Albert Einstein College of Medicine led by Ana Maria Cuervo, M.D., Ph.D., successfully […]
DALLAS, March 29, 2022 /PRNewswire/ — Dynamic Infusion Therapy, LLC (“DIT”), a market leading provider of outsourced vascular access services, has announced the acquisition of Vascular Access Consultants based in Austin, Texas. Vascular Access Consultants has been providing expert services to healthcare facilities in Austin and the surrounding areas for the past 26 years under […]
– Proceeds to fund ACCESS 2 – a randomized clinical trial evaluating Sirogen™ for improving hemodialysis AV Fistula outcomes in high-risk patients – CRESSKILL, N.J., March 29, 2022 /PRNewswire/ — Vascular Therapies, Inc. a clinical-stage biopharma company focused on improving vascular access outcomes in patients with kidney disease, today announced the closing […]
SOUTH SAN FRANCISCO, Calif., March 29, 2022 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that it is partnering with the HeartBrothers Foundation as a corporate […]
— Advancing late-stage clinical and preclinical programs of the Human Acellular Vessel™ (HAV™) and other engineered tissues across several indications – — Multiple publications and scientific meeting presentations highlighting clinical and preclinical HAV results – — Conference call and live webcast at 8:00 am ET today – DURHAM, N.C., March […]
Further analysis from FIDELITY, a prespecified pooled analysis of FIDELIO-DKD and FIGARO-DKD, explores the effect of KERENDIA® (finerenone) on cardiovascular (CV) and kidney outcomes in patients with chronic kidney disease associated with type 2 diabetes, with and without history of CV disease First Phase IIb PACIFIC trial, PACIFIC-AF, gathered information about […]
Global collaborative aims to improve cardiovascular health NEW YORK–(BUSINESS WIRE)–Accenture (NYSE: ACN) has joined AI4BetterHearts, a global data collaborative founded by Microsoft and the Novartis Foundation, that aims to help stakeholders— from policy makers to patients— make better decisions about heart health and improve the health of entire populations. Cardiovascular […]
This innovative study is the first to characterize the metabolites of TOTUM•070 in humans and their mode of action in the liver in a population of 10 healthy volunteers. TOTUM•070 was tested at its clinical daily dose (5g), used also in the Phase II HEART clinical trial. Metabolomic analysis confirms […]
− NorthStar positioned for continued strong growth and setting leadership standards for domestic, environmentally sustainable radioisotope production across its portfolio to meet needs of health systems, radiopharmacies and patients – − NorthStar continues as the only U.S. commercial producer of diagnostic imaging radioisotopes non-uranium molybdenum-99 (Mo-99)/technetium-99m (Tc-99m), for more than […]
Data from RADIANCE-II will build on evidence from RADIANCE-HTN SOLO and TRIO studies to support pre-market application to the FDA PALO ALTO, Calif.–(BUSINESS WIRE)–ReCor Medical, Inc. (“ReCor”), a fully owned subsidiary of Otsuka Medical Devices Co., Ltd., announced today completion of enrollment in their RADIANCE-II pivotal trial of the Paradise […]
